Agios Pharmaceuticals, Inc. (AGIO) Insider Ownership

Historic Insider Ownership Trends

AGIO's three largest insider shareholders as of March 23, 2026 are Brian Goff (Chief Executive Officer, 164.55K shares), Jacqualyn A Fouse (Director, 151.34K shares), David P Schenkein (Director, 126.24K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Brian Goff Chief Executive Officer 164,548 0 03 Mar, 2026
Jacqualyn A Fouse 151,340 0 23 Jun, 2025
David P Schenkein 126,242 0 17 Jun, 2024
Sarah Gheuens Chief Medical Officer 74,406 0 03 Mar, 2026
Cecilia Jones Chief Financial Officer 49,328 0 03 Mar, 2026
James William Burns Chief Legal Officer 44,086 0 03 Mar, 2026
Tsveta Milanova Chief Commercial Officer 41,591 0 03 Mar, 2026
John Maraganore 30,028 0 24 May, 2022
Jonathan Biller Chief Financial Officer 22,953 0 23 Feb, 2022
David Scadden 17,603 0 14 Nov, 2025
Maykin Ho 17,032 0 23 Jun, 2025
Bruce Car Chief Scientific Officer 16,752 0 23 Feb, 2022
Christopher Bowden Chief Medical Officer 15,487 0 22 Jun, 2021
Cynthia Smith 12,414 0 13 Aug, 2025
Rahul D. Ballal 12,414 0 13 Aug, 2025
Richa Poddar Chief Commercial Officer 8,508 0 18 Oct, 2022
Kaye I Foster-Cheek 7,468 0 23 Jun, 2025
Darrin Miles Chief Commercial Officer 7,209 0 18 May, 2021
Ian T Clark 6,549 0 24 May, 2022
Paul J Clancy 6,549 0 24 May, 2022
Adams Catherine Owen 6,073 0 23 Jun, 2025
Jeffrey D Capello 6,073 0 23 Jun, 2025
Krishnan Viswanadhan Chief Corp Dev Strategy 5,141 0 09 Mar, 2026
Theodore James Jr. Washburn Principal Accounting Officer 868 0 05 Mar, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
05 Mar, 2026 Krishnan Viswanadhan Common stock A 8,100 $0.00 8,100 D M
05 Mar, 2026 Krishnan Viswanadhan Common stock D 2,959 $27.80 5,141 D S
05 Mar, 2026 Krishnan Viswanadhan Restricted stock units D 8,100 $0.00 16,200 D M
03 Mar, 2026 Theodore James Jr. Washburn Common stock D 5,272 $28.88 868 D S
02 Mar, 2026 James William Burns Common stock A 4,000 $0.00 35,718 D M
02 Mar, 2026 Cecilia Jones Common stock A 2,000 $0.00 39,394 D M
01 Mar, 2026 Krishnan Viswanadhan Restricted stock units A 14,000 $0.00 14,000 D A
02 Mar, 2026 Brian Goff Common stock A 8,500 $0.00 151,603 D M
02 Mar, 2026 Sarah Gheuens Common stock A 4,000 $0.00 68,795 D M
02 Mar, 2026 Tsveta Milanova Common stock A 5,666 $0.00 40,459 D M
02 Mar, 2026 Theodore James Jr. Washburn Common stock A 2,350 $0.00 3,293 D M
01 Mar, 2026 Krishnan Viswanadhan Stock options (right to buy) A 52,000 $0.00 52,000 D A
02 Mar, 2026 Brian Goff Common stock D 3,870 $28.96 147,733 D S
02 Mar, 2026 Tsveta Milanova Common stock D 1,681 $28.96 38,778 D S
02 Mar, 2026 James William Burns Common stock D 1,187 $28.96 34,531 D S
02 Mar, 2026 Sarah Gheuens Common stock D 1,187 $28.96 67,608 D S
02 Mar, 2026 Theodore James Jr. Washburn Common stock D 698 $28.96 2,595 D S
02 Mar, 2026 Cecilia Jones Common stock D 594 $28.96 38,800 D S
02 Mar, 2026 Theodore James Jr. Washburn Common stock A 2,450 $0.00 4,970 D M
02 Mar, 2026 James William Burns Common stock A 5,666 $0.00 40,197 D M